David S. Wichmann
CIK: 0001268489
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
About WICHMANN DAVID S
WICHMANN DAVID S (SEC CIK 0001268489) files insider reports with the SEC as Director of BOSTON SCIENTIFIC CORP (BSX) and Director of Privia Health Group, Inc. (PRVA).
Signal8 holds 3 ownership filings by WICHMANN DAVID S, all Form 4s, filed between May 9, 2025 and May 11, 2026. Those filings report 3 transactions, from May 8, 2025 to May 7, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on WICHMANN DAVID S's filings is in MARLBOROUGH, MA.
Recent filings by WICHMANN DAVID S
Other insiders filing for BOSTON SCIENTIFIC CORP (BSX)
- O'Sullivan Miriam, SVP, Chief HR Officer
- O'Connor Padraig Andrew, EVP, Global Operations
- Morano Susan E, Director
- Woodworth Emily, SVP, Global Controller and CAO
- Monson Jonathan, EVP and CFO
- Habiger David C, Director